Verisante Technology Inc
Verisante Technology Inc. does not have significant operations. Previously, the company was involved in the design and manufacture of cancer diagnostic devices. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011. Verisante Technology Inc. was incorporated in 2006 and is based in Vancouver, Canada.
Verisante Technology Inc (VRSEF) - Net Assets
Latest net assets as of September 2025: $-156.91K USD
Based on the latest financial reports, Verisante Technology Inc (VRSEF) has net assets worth $-156.91K USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($5.61K) and total liabilities ($162.52K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-156.91K |
| % of Total Assets | -2798.52% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | -105.48% |
| Growth Volatility | 259.89 |
Verisante Technology Inc - Net Assets Trend (2008–2024)
This chart illustrates how Verisante Technology Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Verisante Technology Inc (2008–2024)
The table below shows the annual net assets of Verisante Technology Inc from 2008 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-70.14K | -516.72% |
| 2023-12-31 | $-11.37K | -135.13% |
| 2022-12-31 | $-4.84K | +99.69% |
| 2021-12-31 | $-1.56 Million | -14.06% |
| 2020-12-31 | $-1.37 Million | -3.32% |
| 2019-12-31 | $-1.32 Million | -3.90% |
| 2018-12-31 | $-1.27 Million | +48.49% |
| 2017-12-31 | $-2.47 Million | -884.20% |
| 2016-12-31 | $-251.26K | -119.64% |
| 2015-12-31 | $1.28 Million | -59.59% |
| 2014-12-31 | $3.17 Million | -33.37% |
| 2013-12-31 | $4.75 Million | -21.22% |
| 2012-12-31 | $6.03 Million | -25.28% |
| 2011-12-31 | $8.07 Million | +489.58% |
| 2010-12-31 | $1.37 Million | +2.08% |
| 2009-12-31 | $1.34 Million | +607.26% |
| 2008-12-31 | $189.67K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Verisante Technology Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2280131800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $19.07 Million | % |
| Other Components | $5.01 Million | % |
| Total Equity | $-70.14K | 100.00% |
Verisante Technology Inc Competitors by Market Cap
The table below lists competitors of Verisante Technology Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Eclipsys Corp
OTCQB:ECLP
|
$52.60K |
|
RENTOKIL INITIAL (RTO1.SG)
STU:RTO1
|
$52.67K |
|
TRANSOCEAN N - Dusseldorf Stock Exchang
DU:TOJ
|
$52.69K |
|
GBK Beteiligungen AG
HM:GBQ
|
$52.71K |
|
Bearclaw Capital Corp
V:BRL-H
|
$52.55K |
|
CH SHENHUA ENGY -H- (IKF.SG)
STU:IKF
|
$52.43K |
|
Marshalls PLC
LSE:MSLH
|
$52.42K |
|
AS Harju Elekter
STU:HD8
|
$52.33K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Verisante Technology Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -11,373 to -70,139, a change of -58,766.
- Net loss of 114,767 reduced equity.
- Other comprehensive income increased equity by 1,000,000.
- Other factors decreased equity by 943,999.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-114.77K | -163.63% |
| Other Comprehensive Income | $1.00 Million | +1425.74% |
| Other Changes | $-944.00K | -1345.9% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Verisante Technology Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | $0.09 | $0.01 | x |
| 2009-12-31 | $0.54 | $0.01 | x |
| 2010-12-31 | $0.40 | $0.01 | x |
| 2011-12-31 | $1.48 | $0.01 | x |
| 2012-12-31 | $0.93 | $0.01 | x |
| 2013-12-31 | $0.66 | $0.01 | x |
| 2014-12-31 | $0.39 | $0.01 | x |
| 2015-12-31 | $0.14 | $0.01 | x |
| 2016-12-31 | $-0.03 | $0.01 | x |
| 2017-12-31 | $-0.26 | $0.01 | x |
| 2018-12-31 | $-0.13 | $0.01 | x |
| 2019-12-31 | $-0.13 | $0.01 | x |
| 2020-12-31 | $-0.14 | $0.01 | x |
| 2021-12-31 | $-0.16 | $0.01 | x |
| 2022-12-31 | $0.00 | $0.01 | x |
| 2023-12-31 | $0.00 | $0.01 | x |
| 2024-12-31 | $0.00 | $0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Verisante Technology Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-66.67%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | -466.66% | 0.00% | 0.00x | 1.21x | $-904.09K |
| 2009 | -64.24% | -2829.25% | 0.02x | 1.07x | $-995.91K |
| 2010 | -108.42% | -13012.55% | 0.01x | 1.11x | $-1.62 Million |
| 2011 | -43.98% | -157892.53% | 0.00x | 1.09x | $-4.36 Million |
| 2012 | -58.20% | 0.00% | 0.00x | 1.13x | $-4.11 Million |
| 2013 | -103.02% | -631.51% | 0.14x | 1.14x | $-5.37 Million |
| 2014 | -102.10% | -1477.68% | 0.05x | 1.49x | $-3.55 Million |
| 2015 | -186.74% | -1719.00% | 0.04x | 2.63x | $-2.52 Million |
| 2016 | 0.00% | -6218.13% | 0.01x | 0.00x | $-1.62 Million |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.03 Million |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $558.75K |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $82.71K |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $92.78K |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-36.29K |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $1.20 Million |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-89.39K |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-107.75K |
Industry Comparison
This section compares Verisante Technology Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Verisante Technology Inc (VRSEF) | $-156.91K | -466.66% | N/A | $52.59K |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |